Hemodynamic effects of dexmedetomidine in critically ill neonates and infants with heart disease

Pediatric Cardiology

Volumn 33, Issue 7, 2012, Pages 1069-1077

  Lam, Francis ^a   Bhutta, Adnan T ^b   Tobias, Joseph D ^c   Gossett, Jeffrey M ^a   Morales, Laura ^a   Gupta, Punkaj ^b  

^a UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^b UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Congenital heart disease; Dexmedetomidine; Heart transplantation; Hemodynamic effect; Infants; RACHS 1

Indexed keywords

DEXMEDETOMIDINE; MIDAZOLAM; MORPHINE;

ABDOMINAL DISTENSION; ARTICLE; CENTRAL VENOUS PRESSURE; CONGENITAL HEART DISEASE; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DEMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ARRHYTHMIA; HEART HEMODYNAMICS; HEART RATE; HEART SINGLE VENTRICLE; HEART TRANSPLANTATION; HUMAN; INFANT; INFANT DISEASE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEDICAL RECORD REVIEW; NAUSEA; NEAR INFRARED SPECTROSCOPY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SEIZURE; THERAPY EFFECT; VOMITING;

CHILD, PRESCHOOL; CRITICAL ILLNESS; DEXMEDETOMIDINE; FEMALE; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; LINEAR MODELS; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84867877845     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-012-0227-6     Document Type: Article

References (25)

1. Anand KJ, Hickey PR (1992) Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. N Engl J Med 326:1-9
2. Barton KP, Munoz R, Morell VO, Chrysostomou C (2008) Dexmedetomidine as the primary sedative during invasive procedures in infants and toddlers with congenital heart disease. Pediatr Crit Care Med 9:612-615
3. Bejian S, Valasek C, Nigro JJ, Cleveland DC, Willis BC (2009) Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit. Cardiol Young 19:98-104
4. Belleville JP, Ward DS, Bloor BC et al (1992) Effects of intravenous dexmedetomidine in humans: Part I. Sedation, ventilation, and metabolic rate. Anesthesiology 77:1125-1133
5. Bloor BC, Ward DS, Belleville JP et al (1992) Effects of intravenous dexmedetomidine in humans: II Hemodynamic changes. Anesthesiology 77:1134-1142
6. Buck ML, Willson DF (2008) Use of dexmedetomidine in the pediatric intensive care unit. Pharmacotherapy 28:1-57
7. Chrysostomou C, Zeballos T (2005) Use of dexmedetomidine in a pediatric heart transplant patient. Pediatr Cardiol 26:651-654
8. Chrysostomou C, Di Filippo S, Manrique AM et al (2006) Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med 7:126-131
9. Chrysostomou C, Sanchez De Toledo J, Avolio T, Motoa MV, Berry D, Morell VO, Orr R, Munoz R (2009) Dexmedetomidine use in a pediatric cardiac intensive care unit: can we use it in infants after cardiac surgery? Pediatr Crit Care Med 10:654-660
10. Darnell C, Steiner J, Szmuk P et al (2010) Withdrawal from multiple sedative agent therapy in an infant: is dexmedetomidine the cause or the cure? Paediatr Crit Care Med 11:e1-e3
11. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al (2008) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Int Care Med 34:17-60
12. Ebert TJ, Hall JE, Barney JA et al (2000) The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93:382-394
13. Eisenach JC (1994) Alpha2-agonists and analgesia. Expert Opin Invest Drugs 3:1005-1010
14. Hosokawa K, Shime N, Kato Y et al (2010) Dexmedetomidine sedation in children after cardiac surgery. Pediatr Crit Care Med 11:39-43
15. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI (2002) Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 123:110-118
16. Ko WJ, Lin CY, Chen RJ, Wang SS, Lin FY, Chen YS (2002) Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg 73:538-545
17. Koroglu A, Demirbilek S, Teksan H et al (2005) Sedative, haemodynamic, and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth 94:821-824
18. Le KN, Moffett BS, Ocampo EC, Zaki J, Mossad EB (2011) Impact of dexmedetomidine on early extubation in pediatric cardiac surgical patients. Intensive Care Med 37:686-690
19. Pichot C, Géloen A, Ghignone M, Quintin L (2010) Alpha-2 agonists to reduce vasopressor requirements in septic shock? Med Hypotheses 75:652-656
20. Tobias JD (2000) Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care units. Crit Care Med 28:2122-2132
21. Tobias JD (2007) Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med 8:115-131
22. Tobias JD (2010) Dexmedetomidine: are there going to be issues with prolonged administration? J Pediatr Pharmacol Ther 15:4-9
23. Venn RM, Grounds RM (2001) Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 87:684-690
24. Weber MD, Thammasitboon S, Rosen DA (2008) Acute discontinuation syndrome from dexmedetomidine after protracted use in a pediatric patient. Paediatr Anaesth 18:87-88
25. Zornow MH (1991) Ventilatory, hemodynamic, and sedative effects of the alpha2-adrenergic agonist, dexmedetomidine. Neuropharmacology 30(10):1065-1071